Related Experiment Videos
Transformed liver cells have modified transplasma membrane redox activity which is sensitive to adriamycin
Biochemical and Biophysical Research Communications
|October 14, 1983
Abstract:
Electron transport across the plasma membrane is found in all cells which have been tested. This activity has been implicated in control of cellular growth, transport and hormone response. In virus transformed cells and tumor cells we find the activity is decreased and becomes sensitive to the antitumor drug adriamycin. Inhibition of transmembrane redox by adriamycin parallels cytoxicity to transformed cells.
Insights
Electron transport across cell membranes is crucial for cellular functions. This activity decreases in tumor cells and becomes sensitive to adriamycin, an antitumor drug, indicating a potential therapeutic target.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Electron transport across the plasma membrane is a fundamental cellular process observed in all tested cell types.
- This transmembrane electron transport activity plays a role in regulating cellular growth, transport mechanisms, and hormone responses.
Purpose of the Study:
- To investigate alterations in plasma membrane electron transport activity in virus-transformed and tumor cells.
- To determine the effect of the antitumor drug adriamycin on this activity in cancerous cells.
Main Methods:
- Assessing electron transport activity across the plasma membrane in various cell types.
- Comparing activity levels in normal, virus-transformed, and tumor cells.
- Evaluating the sensitivity of this activity to adriamycin treatment.
Main Results:
- Electron transport activity across the plasma membrane is significantly decreased in virus-transformed and tumor cells compared to normal cells.
- The diminished electron transport activity in these malignant cells exhibits increased sensitivity to the antitumor drug adriamycin.
- Inhibition of transmembrane redox by adriamycin correlates directly with its cytotoxic effects on transformed cells.
Conclusions:
- Plasma membrane electron transport is altered in cancer cells, presenting a potential biomarker.
- Adriamycin's mechanism of action involves the inhibition of transmembrane redox, leading to cytotoxicity in transformed cells.
- Targeting transmembrane electron transport with drugs like adriamycin shows promise for cancer therapy.